485 related articles for article (PubMed ID: 30772013)
1. Tissue characteristics of culprit lesion and myocardial tissue-level perfusion in non-ST-segment elevation acute coronary syndromes: The EARLY-MYO-ACS study.
Yang G; Wang W; Sheng X; Yang F; Kong L; He J; Ding S; Shan P; Shang Y; Xiu J; Yang Y; Mintz GS; Pu J
Int J Cardiol; 2019 Jul; 287():32-38. PubMed ID: 30772013
[TBL] [Abstract][Full Text] [Related]
2. Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial.
Batra G; Renlund H; Kunadian V; James SK; Storey RF; Steg PG; Katus HA; Harrington RA; Gibson CM; Budaj A; Siegbahn A; Wallentin L
Eur Heart J Acute Cardiovasc Care; 2022 Jun; 11(4):336-349. PubMed ID: 35213721
[TBL] [Abstract][Full Text] [Related]
3. Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy).
Lansky AJ; Ng VG; Meller S; Xu K; Fahy M; Feit F; Ohman EM; White HD; Mehran R; Bertrand ME; Desmet W; Hamon M; Stone GW
JACC Cardiovasc Interv; 2014 Mar; 7(3):266-75. PubMed ID: 24650400
[TBL] [Abstract][Full Text] [Related]
4. iMap intravascular ultrasound evaluation of culprit and non-culprit lesions in patients with ST-elevation myocardial infarction.
Trusinskis K; Juhnevica D; Strenge K; Erglis A
Cardiovasc Revasc Med; 2013; 14(2):71-5. PubMed ID: 23332592
[TBL] [Abstract][Full Text] [Related]
5. Tissue characterization and phenotype classification in patients presenting with acute myocardial infarction: Insights from the iWonder study.
Souza CF; Maehara A; Mintz GS; Matsumura M; Alves CMR; Carlos Carvalho A; Caixeta A
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1107-1114. PubMed ID: 28191713
[TBL] [Abstract][Full Text] [Related]
6. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
Kunadian V; James SK; Wojdyla DM; Zorkun C; Wu J; Storey RF; Steg PG; Katus H; Emanuelsson H; Horrow J; Maya J; Wallentin L; Harrington RA; Gibson CM
JACC Cardiovasc Interv; 2013 Jul; 6(7):671-83. PubMed ID: 23866179
[TBL] [Abstract][Full Text] [Related]
7. Impact of culprit plaque volume and composition on myocardial microcirculation following primary angioplasty in patients with ST-segment elevation myocardial infarction: virtual histology intravascular ultrasound analysis.
Ohshima K; Ikeda S; Kadota H; Yamane K; Izumi N; Ohshima K; Hamada M
Int J Cardiol; 2013 Aug; 167(3):1000-5. PubMed ID: 22481047
[TBL] [Abstract][Full Text] [Related]
8. Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes.
Bolognese L; Ducci K; Angioli P; Falsini G; Liistro F; Baldassarre S; Burali A
Circulation; 2004 Sep; 110(12):1592-7. PubMed ID: 15353489
[TBL] [Abstract][Full Text] [Related]
9. Prognostic utility of myocardial blush grade after PCI in patients with NSTE-ACS: Analysis from the ACUITY trial.
Ng VG; Lansky AJ; Toro S; Parise H; Cristea E; Mehran R; Stone GW
Catheter Cardiovasc Interv; 2016 Aug; 88(2):215-24. PubMed ID: 25641255
[TBL] [Abstract][Full Text] [Related]
10. Reduction of atherothrombotic burden before stent deployment in non-ST elevation acute coronary syndromes: Reduction of myocardial necrosis achieved with nose-dive manual thrombus aspiration (REMNANT) trial. A volumetric intravascular ultrasound study.
Zimarino M; Angeramo F; Prasad A; Ruggieri B; Malatesta S; Prati F; Buttitta F; De Caterina R
Catheter Cardiovasc Interv; 2016 Nov; 88(5):716-725. PubMed ID: 26527239
[TBL] [Abstract][Full Text] [Related]
11. Tissue characteristics of non-culprit plaque in patients with acute coronary syndrome vs. stable angina: a color-coded intravascular ultrasound study.
Sudo M; Hiro T; Takayama T; Iida K; Nishida T; Fukamachi D; Kawano T; Higuchi Y; Hirayama A
Cardiovasc Interv Ther; 2016 Jan; 31(1):42-50. PubMed ID: 26188645
[TBL] [Abstract][Full Text] [Related]
12. Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trial.
De Luca G; Brener SJ; Mehran R; Lansky AJ; McLaurin BT; Cox DA; Cristea E; Fahy M; Stone GW
Int J Cardiol; 2013 Aug; 167(3):727-32. PubMed ID: 22464479
[TBL] [Abstract][Full Text] [Related]
13. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
[TBL] [Abstract][Full Text] [Related]
14. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with non-ST segment elevation acute coronary syndrome.
Lee T; Murai T; Isobe M; Kakuta T
Catheter Cardiovasc Interv; 2017 Nov; 90(6):905-914. PubMed ID: 28303685
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates and prognostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes.
Careri G; Nerla R; Di Monaco A; Russo G; Stazi A; Villano A; Sestito A; Lanza GA; Crea F
Am J Cardiol; 2013 Jan; 111(1):51-7. PubMed ID: 23062313
[TBL] [Abstract][Full Text] [Related]
16. Comparison of virtual histology to intravascular ultrasound of culprit coronary lesions in acute coronary syndrome and target coronary lesions in stable angina pectoris.
Hong MK; Mintz GS; Lee CW; Suh J; Kim JH; Park DW; Lee SW; Kim YH; Cheong SS; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2007 Sep; 100(6):953-9. PubMed ID: 17826376
[TBL] [Abstract][Full Text] [Related]
17. Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study.
Dohi T; Mintz GS; McPherson JA; de Bruyne B; Farhat NZ; Lansky AJ; Mehran R; Weisz G; Xu K; Stone GW; Maehara A
JACC Cardiovasc Imaging; 2013 Aug; 6(8):908-16. PubMed ID: 23850249
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of culprit atheromatous plaques obtained in vivo by intravascular ultrasound radiofrequency analysis: results from the CULPLAC study.
Cascón-Pérez JD; de la Torre-Hernández JM; Ruiz-Abellón MC; Martínez-Pascual M; Mármol-Lozano R; López-Candel J; Cano P; Fernández C; Ramos JL; Villegas M; Picó-Aracil F
Am Heart J; 2013 Mar; 165(3):400-7. PubMed ID: 23453110
[TBL] [Abstract][Full Text] [Related]
19. Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Shiono Y; Kubo T; Tanaka A; Tanimoto T; Ota S; Ino Y; Aoki H; Ozaki Y; Orii M; Shimamura K; Ishibashi K; Yamano T; Yamaguchi T; Hirata K; Imanishi T; Akasaka T
JACC Cardiovasc Interv; 2013 Aug; 6(8):847-53. PubMed ID: 23871509
[TBL] [Abstract][Full Text] [Related]
20. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction.
Wong GC; Morrow DA; Murphy S; Kraimer N; Pai R; James D; Robertson DH; Demopoulos LA; DiBattiste P; Cannon CP; Gibson CM
Circulation; 2002 Jul; 106(2):202-7. PubMed ID: 12105159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
